Find and Pitch Jounalists, Get Your Story Covered

Tags: MDMA ecstasy PTSD therapy Front Page Reports

	Profile	Recent Articles on Subject
1	Lizzy Lawrence STAT News Medical devices reporter at STATnews. Loves news tips. medical reportingnews	STAT+: FDA to staff: No need to work from pantries for now - 6 days ago STAT+: 3 key issues to watch at the FDA as Trump takes office - 3 months ago STAT+: Eli Lilly weight loss drug shortage underscores deeper issues with FDA oversight - 5 months ago STAT+: Another suit filed against FDA over lab-developed test rule - 8 months ago STAT+: FDA warns medical device makers about rise in fabricated data - about 1 year ago
2	Jonathan Gardner MedTech Dive Senior reporter. BioPharma Dive. Charlottesville, Virginia BiopharmaceuticalsJournalism	Makary confirmed by Senate as FDA commissioner - 8 days ago FTC challenges patents held by nine big drugmakers, citing unfair competition - over 1 year ago FTC challenges patents held by nine big drugmakers, citing unfair competition - over 1 year ago
3	Ed Silverman STAT News Pharmalot columnist. Senior writer at STATnews. pharmaceutical industry	STAT+: FDA scolds drugmaker over promotion that touts ‘misleading’ comparison with generics - 30 days ago STAT+: Pharmalittle: We’re reading about FDA morale, pharma removing DEI goals, and more - about 2 months ago STAT+: Pharmalittle: We’re reading about an FDA hold on an Amgen obesity drug, imported Canadian drugs, and more - about 2 months ago STAT+: Pharmalittle: We’re reading about FDA commish’s parting thoughts, a warning on RSV shots, and more - 3 months ago STAT+: Pharmalittle: We’re reading about FDA guidance on AI, meds releasing ‘forever chemicals,’ and more - 3 months ago STAT+: Pharmalittle: We’re reading about picking an FDA chief, a menopause film controversy, and more - 4 months ago STAT+: Eli Lilly weight loss drug shortage underscores deeper issues with FDA oversight - 5 months ago STAT+: FDA agrees to review a rare disease drug that its developer was about to give up on - 12 months ago STAT+: FDA is still struggling to inspect clinical research sites, watchdog finds - about 1 year ago STAT+: FDA gives a mixed response to a petition seeking greater clinical trial transparency - about 1 year ago STAT+: Pharmalittle: We’re reading about Lilly selling drugs directly, UCB leaving BIO, and more news - about 1 year ago STAT+: FDA is blasted by advocates for pursuing a deal with data provider that has ties to opioid makers - about 1 year ago STAT+: Pharmalittle: FDA approvals rebound, abortion pill orders rise, and more news - over 1 year ago STAT+: In response to criticism, FDA publishes new database of wayward clinical trial sponsors - over 1 year ago STAT+: ‘Learning each other’s language’: FDA, patent office seek to work together to lower drug prices - over 1 year ago STAT+: FDA efforts to oversee foreign drug manufacturing remain inadequate to ensure safety, analysis finds - over 1 year ago STAT+: Pharmalittle: Woodcock to retire from the FDA; Acrotech urged to speed up confirmatory study of cancer drugs - over 1 year ago STAT+: More drug and device patents were invalidated for bad info than those filed by other industries, analysis finds - over 1 year ago STAT+: Pharmalittle: FTC challenges ‘inaccurately or improperly’ listed patents; Elliott builds stake in BioMarin - over 1 year ago STAT+: Pharmalittle: Pharma trade group slams European Commission proposal; U.S. lawmakers demand FDA explain its approach to shortages - over 1 year ago
4	Elise Reuter MedTech Dive Reporter @MedTechDive. Covers medical devices. medical technologydigital therapeutics	Judge orders FDA, health agencies to restore removed webpages - about 2 months ago Former FDA head Gottlieb calls for less regulation of certain AI tools - about 2 months ago FDA drafts guidance outlining real-world evidence for medical device submissions - over 1 year ago FDA withdraws from Global Harmonization Working Party - over 1 year ago
5	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	What should pharma make of the FDA going dark on DEI? - about 2 months ago 3 recent FDA adcomm rejections — and why they matter - over 1 year ago
6	Nick Paul Taylor MedTech Dive Top 5 Mario Kart Player. Gaming	Tarver warns that US device supply chain vulnerabilities could harm patients - 3 months ago FDA finalizes guidance on device shortage reporting rules - 3 months ago FDA warns 2 Chinese labs for oversight failures, animal care violations - 7 months ago FDA’s plan to expand device surveillance faces challenges, GAO finds - 8 months ago FDA sends 2 warning letters after inspecting Chinese syringe manufacturers - 9 months ago FDA creates communication ‘super office’ at CDRH - 9 months ago House committee tells FDA to suspend lab developed test rule - 9 months ago FDA finalizes guidance on studying opioid use disorder treatments - 9 months ago FDA to expand total product life cycle program - 9 months ago FDA seeks feedback on expansion of premarket cybersecurity guidance - about 1 year ago FDA warns industry of ‘fraudulent’ third-party data in device applications - about 1 year ago FDA authorizes record number of new devices in 2023 - about 1 year ago FDA acts on industry call for clarity about scope of device shortage reporting rules - over 1 year ago FDA finalizes COVID-era guidance, extending flexibility for some remote monitoring devices - over 1 year ago FDA expands total product life cycle program to cover neurological devices - over 1 year ago FDA shares draft medical device harmonization plan to meet MDUFA V goal - over 1 year ago FDA releases draft guidance for studying weight loss devices - over 1 year ago FDA finalizes breakthrough device changes to target health inequities - over 1 year ago House committee tells FDA to suspend lab developed test rule - 9 months ago
7	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	FDA ‘stuck to its corner’ with AI draft guidance, leaving plenty of questions unanswered - 3 months ago FDA’s GLP-1 decision kicks off ‘unprecedented’ tussle over shortage - 5 months ago 3 FDA approval dates to watch in the year’s final push - 7 months ago FDA’s platform designation aims to ease R&D pain points - 10 months ago After ‘tragic’ bacterial outbreak, lawmakers press FDA to step up foreign inspections - about 1 year ago FDA inches closer to defining its regulatory role in AI - about 1 year ago
8	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	STAT+: Eli Lilly weight loss drug shortage underscores deeper issues with FDA oversight - 5 months ago STAT+: FDA cracks down on websites that claim to sell chemicals in obesity drugs Wegovy, Zepbound - about 1 year ago
9	N. Adam Brown MD MedPage Today Healthcare Strategist/Communicator. Washington, D.C. Healthcarestrategycommunication	Direct-to-Consumer Drugs: Big Pharma's Digital Health Play - 7 months ago
10	Brittany Trang STAT News Health care business reporter. PhD. Indie rock fan. health carebusiness reporting	STAT+: ‘Sarepta’s like a curse on me’: FDA commissioner dismisses controversy over Elevidys - 7 months ago

Journalists covering FDA